🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Sung Gwe Ahn

Yonsei University

ORCID: 0000-0002-8778-9686

Also affiliated with Breast Cancer Research Foundation, Severance Hospital, Gangnam Severance Hospital, Yonsei University Health System

Biochemistry, Genetics and Molecular BiologyMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “Nodal Burden and Oncologic Outcomes in Patients With Residual Isolated Tumor Cells After Neoadjuvant Chemotherapy (ypN0i+): The OPBC-05/ICARO Study”.

Nodal Burden and Oncologic Outcomes in Patients With Residual Isolated Tumor Cells After Neoadjuvant Chemotherapy (ypN0i+): The OPBC-05/ICARO Study

Journal of Clinical Oncology(2024)10.1200/jco.24.01052

N/A

0.825DataRank · unranked

43 citations

Alison Laws, Massimo Ferrucci, Mary M. Mrdutt, Susie X. Sun, Süleyman Bademler +95 more

Oncological outcomes with and without axillary lymph node dissection in patients with residual micrometastases after neoadjuvant chemotherapy (OPBC-07/microNAC): an international, retrospective cohort study

The Lancet Oncology(2025)10.1016/s1470-2045(25)00598-4

N/A

0.416DataRank · unranked

15 citations

Michael Alvarado, Sara Myers, Mary M Mrdutt, Susie X. Sun, Varadan Sevilimedu +95 more

Prognostic value of residual disease (RD) biology and gene expression changes during the neoadjuvant treatment in patients with HER2-positive early breast cancer (EBC)

Annals of Oncology(2024)10.1016/j.annonc.2024.12.010

N/A

0DataRank · unranked

3 citations

Maki Tanioka, Sung Gwe Ahn, Paola Zagami, Tomás Pascual, Mattia Rediti +18 more